Pharmaceuticals
Pharmacosmos is at the forefront of intravenous iron therapy. We continue to expand our global footprint by seeking dedicated partners who share our vision of transforming the way iron deficiency anaemia is treated.
Our expertise in iron extends to veterinary medicine. Pharmacosmos is actively seeking partners in a number of markets, including France (registered), Brazil, and Japan.
Pharmacosmos is a leading manufacturer and developer of injectable iron for the prevention and treatment of iron deficiency anaemia in humans and animals. Our injectable iron brand for prevention and treatment of iron deficiency anaemia in pigs, Uniferon®, is market through dedicated partners in more than 24 countries. Our injectable iron is a proprietary Pharmacosmos product optimised for use in veterinary medicine, and it is supported by a strong brand platform and farm-level anaemia management insight. Optimal partners are companies with full sales coverage of their local market, strong competences in veterinary medicine, and dedication to bringing optimal iron care to their local veterinarians and farmers.
To learn more, please contact Christian von der Recke-Heisel at info@pharmacosmos.com
Pharmacosmos is actively seeking skilled partners for Uniferon® in markets where we are not yet present, including France (registered), Latin America – especially Mexico, Brazil and Argentina – and Japan.
To learn more, please contact Christian von der Recke-Heisel at info@pharmacosmos.com
We are looking to in-license complementary pig products for our affiliate in the US within antibiotics, vaccines, etc. We are seeking US rights only and our focus is on complex and innovative products with IP protection and a scientific content in either late development, in the filing phase, or already approved.
To learn more, please contact Christian von der Recke-Heisel at info@pharmacosmos.com
Pharmacosmos is a leader in iron carbohydrate complexity and operates a fully integrated, FDA- and EMA-approved, factory in Denmark. Our iron dextran API is manufactured with pharmaceutical quality dextrans in line with the US, European and Japanese pharmacopeias.
Our API business focuses on both existing and new registrations, supported by access to our ASMF/DMF, and use for new applications within veterinary medicine.
To learn more, please contact Christian von der Recke-Heisel at info@pharmacosmos.com
We collaborate with leading universities and practitioners around the world in driving research to uncover new clinical insights into iron metabolism and iron deficiency in pigs that have the potential to impact modern pig production. This is about exploring new frontiers, with a constant eye on improvements in safety and efficacy. We are actively seeking opportunities to collaborate on internships, investigator-sponsored studies, etc. for the evaluation of current pig production, testing protocol developments, and for the set-up and execution of new research and development field trials.
To learn more, please contact Wesley Lyons at info@pharmacosmos.com
A global pioneer in carbohydrate chemistry and a leader in the development of innovative treatments for patients suffering from iron deficiency and iron deficiency anaemia.